Baylor Genetics / coverage

About

For families affected by rare disease, the road to a diagnosis can be long. Baylor Genetics had data showing how whole genome sequencing can shorten it, and it wanted that message in front of the rare disease community.

SVM secured an interview for Baylor Genetics’ Chief Medical Officer, Christine Eng, MD, with CheckRare. The resulting piece, “How Whole Genome Sequencing Can Lead to Early Diagnosis and Intervention,” draws on data Baylor presented at recent industry events.

The interview carried Baylor’s conference data to the clinicians and advocates who follow rare disease news.